Islet amyloid with macrophage migration correlates with augmented β-cell deficits in type 2 diabetic patients

Amyloid

Volumn 21, Issue 3, 2014, Pages 191-201

  Kamata, Kosuke ^a   Mizukami, Hiroki ^a   Inaba, Wataru ^a   Tsuboi, Kentaro ^a   Tateishi, Yoshinori ^a   Yoshida, Taro ^a   Yagihashi, Soroku ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Macrophage; Morphometry; Oxidative stress; Pancreatic islet; Type 2 diabetes; cell loss

Indexed keywords

AMYLOID; BIOLOGICAL MARKER; HEMOGLOBIN A1C; HISTONE H2AX; MESSENGER RNA; PROINSULIN; AMYLIN; GLYCOSYLATED HEMOGLOBIN; H2AFX PROTEIN, HUMAN; HEMOGLOBIN A1C PROTEIN, HUMAN; HISTONE;

AGED; ARTICLE; AUTOPSY; BODY MASS; CELL DAMAGE; CELL DENSITY; CELL INFILTRATION; CELL LOSS; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE DURATION; DNA DAMAGE; FEMALE; HUMAN; HUMAN TISSUE; JAPANESE (PEOPLE); MACROPHAGE MIGRATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; CASE CONTROL STUDY; CELL MOTION; DEFICIENCY; GENE EXPRESSION; GENETICS; JAPAN; MACROPHAGE; METABOLISM; MIDDLE AGED; ORGAN SIZE; PATHOLOGY;

AGED; AUTOPSY; CASE-CONTROL STUDIES; CELL MOVEMENT; DIABETES MELLITUS, TYPE 2; DNA DAMAGE; FEMALE; GENE EXPRESSION; GLUCAGON-SECRETING CELLS; HEMOGLOBIN A, GLYCOSYLATED; HISTONES; HUMANS; INSULIN-SECRETING CELLS; ISLET AMYLOID POLYPEPTIDE; JAPAN; MACROPHAGES; MALE; MIDDLE AGED; ORGAN SIZE; OXIDATIVE STRESS; PROINSULIN;

EID: 84906264935     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.3109/13506129.2014.937857     Document Type: Article

References (43)

1. Opie EL. On the relation of diabetes mellitus to lesions of the pancreas. Hyaline degeneration of the islands of Langerhans. J Exp Med 1901;5:527-40.
2. Westermark P, Grimelius L. The pancreatic islet cells in insular amyloidosis in human diabetic and non-diabetic adults. Acta pathol Microbiol Scand Sect A 1973;81:291-300.
3. Maloy AL, Longnecker DS, Greenberg ER. The relation of islet amyloid to the clinical type of diabetes. Hum Pathol 1981;12: 917-22. (Pubitemid 12227621)
4. Clark A, Cooper GJS, Lewis CE, Morris JF, Willis AC, Reid KBM, Turner RC. Islet amyloid formed from diabetes-associated-peptide may be pathogenic in type 2 diabetes. Lancet 1987;ii:231-4. (Pubitemid 17101086)
5. Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD, Johnson KH. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci USA 1987;84:3881-5. (Pubitemid 17088383)
6. Cooper GJ, Willis AC, Clark A, Turner RC, Sim RB, Reid KB. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 1987;84:8628-32. (Pubitemid 18033465)
7. Roberts AN, Leighton B, Todd JA, Cockburn D, Schofield PN, Sutton R, Holt S, et al. Molecular and functional characterization of amylin, a peptide associated with type 2 diabetes mellitus. Proc Natl Acad Sci USA 1989;86:9662-6. (Pubitemid 20030693)
8. Westermark P, Engström U, Johnson KH, Westermark GT, Betsholtz C. Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci USA 1990;87:5036-40.
9. Hull RL, Westermark GT, Westermark P, Kahn SE. Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes. J Clin Endocrinol Metab 2004;89:3629-43. (Pubitemid 39071447)
10. Westermark P, Wilander E. The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus. Diabetologia 1978;15:417-21. (Pubitemid 9046993)
11. Clark A, Wells CA, Buley ID, Cruickshank JK, Vanhegan RI, Matthews DR, Cooper GJS, et al. Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res 1988;9:1591-9.
12. Steiner DF, Ohagi S, Nagamatsu S, Bell GI, Nishi M. Is islet amyloid polypeptide a significant factor in pathogenesis or pathophysiology of diabetes? Diabetes 1991;40:305-9.
13. Jurgens CA, Toukatly MN, Fligner CL, Udayasankar J, Subramanian SL, Zraika S, Aston-Mourney K, et al. b-Cell loss and b-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition. Am J Pathol 2011;178:2632-40.
14. Homo-Delarche F, Calderari S, Irminger JC, Gangnerau MN, Coulaud J, Rickenbach K, Dolz M, et al. Islet inflammation and fibrosis in a spontaneous model of type 2 diabetes, the GK rat. Diabetes 2006;55:1625-33. (Pubitemid 44324114)
15. Ehses JA, Perren A, Eppler E, Ribaux P, Pospisilik JA, Maor-Cahn R, Gueripel X, et al. Increased number of isletassociated macrophages in type 2 diabetes. Diabetes 2007;56: 2356-70. (Pubitemid 47358243)
16. Larsen CM, Faulenbach M, Vaag A, Vølund A, Ehses JA, Seifert B, Mandrup-Poulsen T, et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 2007;356:1517-26. (Pubitemid 46588416)
17. Zao HL, Lai FMM, Tong PCY, Zhong DR, Yang D, Tomlinson B. Prevalence and clinicopathological characteristics of islet amyloid in Chinese patients with type 2 diabetes. Diabetes 2003;52: 2759-66. (Pubitemid 37339705)
18. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003;52:102-10. (Pubitemid 36042113)
19. Sakuraba H, Mizukami H, Yagihashi N, Wada R, Hanyu C, Yagihashi S. Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients. Diabetologia 2002;45:85-96. (Pubitemid 34118546)
20. Mizukami H, Takahashi K, Inaba W, Tsuboi K, Kamata K, Yagihashi S. Age-associated changes of islet endocrine cells and the effect of body mass index in Japanese. J Diabetes Invest 2014;5: 38-47.
21. Inaba W, Mizukami H, Kamata K, Takahashi K, Tsuboi K, Yagihashi S. Effects of long-term treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin on islet endocrine cells in nonobese type 2 diabetic Goto-Kakizaki rats. Eur J Pharmacol 2012; 691:297-306.
22. Mah LJ, El-Osta A, Karagiannis TC. gH2AX: a sensitive molecular marker of DNA damage and repair. Leukemia 2010;24:679-86.
23. Kunisch E, Fuhrmann R, Roth A, Winter R, Lungershausen W, Kinne RW. Macrophage specificity of three anti-CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry. Ann Rheum Dis 2004;63: 774-84. (Pubitemid 38850447)
24. Fadini GP, de Kreutzenberg SV, Boscaro E, Albiero M, Cappellari R, Kränkel N, Landmesser U, et al. An unbalanced monocyte polarisation in peripheral blood and bone marrow of patients with type 2 diabetes has an impact on microangiopathy. Diabetologia 2013;56:1856-66.
25. Ciccia F, Alessandro R, Rizzo A, Accardo-Palumbo A, Raimondo S, Raiata F, Guggino G, et al. Macrophage phenotype in the subclinical gut inflammation of patients with ankylosing spondylitis. Rheumatology 2014;53:104-13.
26. Komohara Y, Ohnishi K, Kuratsu J, Takeya M. Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J Pathol 2008;216:15-24.
27. Kawamura K, Komohara Y, Takaishi K, Katabuchi H, Takeya M. Detection of M2 macrophages and colony-stimulating factor 1, expression in serous and mucinous ovarian epithelial tumors. Pathol Int 2009;59:300-5.
28. McKenzie KJ, Hind C, Farquaharson MA, McGill M, Foulis AK. Demonstration of insulin production and storage in insulinomas by in situ hybridization and immunocytochemistry. J Pathol 1997;181: 218-22. (Pubitemid 27087289)
29. de Koning EJ, van den Brand JJ, Mott VL, Charge SB, Hansen BC, Bodkin NL, Morris JF, et al. Macrophages and pancreatic islet amyloidosis. Amyloid 1988;5:247-54.
30. Donath MY. Targeting inflammation in the treatment of type 2 diabetes. Diabetes Obes Metab 2013;15:193-6.
31. Eguchi K, Manabe I. Macrophages and islet inflammation in type 2 diabetes. Diabetes Obes Metab 2013;15:152-8.
32. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006;444:860-7. (Pubitemid 46024993)
33. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr. AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112:1796-808. (Pubitemid 38063703)
34. Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-74. (Pubitemid 36019640)
35. Mantovani A, Garlanda C, Locati M. Macrophage diversity and polarization in atherosclerosis: a question of balance. Arterioscl Thromb Vasc Biol 2009;29:1419-23.
36. Ehses JA, Lacraz G, Giroix MH, Schmidlin F, Coulaud J, Kassis N, Irminger JC, et al. IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat. Proc Natl Acad Sci USA 2009;106:13998-4003.
37. Westwell-Roper C, Dai DL, Soukhatcheva G, Potter KJ, van Rooijen N, Ehses JA, Verchere CB. IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction. J Immunol 2011; 187:2755-65.
38. Masters SL, Dunne A, Subramanian SL, Hull RL, Tannahill GM, Sharp FA, Becker C, et al. Activation of the Nlrp3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1b in type 2 diabetes. Nat Immunol 2010;11:897-904.
39. Lorenzo A, Razzaboni B, Weir GC, Yankner BA. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 1994;368:756-60. (Pubitemid 24153418)
40. Sparr E, Engel MF, Sakharov DV, Sprong M, Jacobs J, de Kruijff B, Höppener JW, et al. Islet amyloid polypeptide-induced membrane leakage involves uptake of lipids by forming amyloid fibers. FEBS Lett 2004;577:117-20. (Pubitemid 39452370)
41. Matveyenko AV, Gurlo T, Daval M, Butler AE, Butler PC. Successful versus failed adaptation to high-fat diet-induced insulin resistance: the role of IAPP-induced beta-cell endoplasmic reticulum stress. Diabetes 2009;58:906-16.
42. Rivera JF, Gurlo T, Daval M, Huang CJ, Matveyenko AV, Butler PC, Costes S. Human-IAPP disrupts the autophagy/ lysosomal pathway in pancreatic b-cells: protective role of p62-positive cytoplasmic inclusions. Cell Death Differ 2011;18: 415-26.
43. Clark A, Holman RR, Mattews DR, McGill M, Foulis AK. Non-uniform distribution of islet amyloid in the pancreas of 'maturity-onset' diabetic patients. Diabetologia 1984;27:527-8. (Pubitemid 15208927)